The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...

Recently, Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a library of live-attenuated influenza A vaccines that utilize ...

COVID-19 vaccines lower the risk of getting sick, seriously ill or dying from the disease. But how do the different types of COVID-19 vaccines work? Each COVID-19 vaccine causes the immune system to ...

(Nanowerk News) A multi-institutional research team with Northwestern Engineering’s Neha Kamat has developed a new method for rapidly assembling vaccine nanoparticles that could improve how the world ...

Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...

Vaccination is a cornerstone of public health, especially in the fight against respiratory viruses that cause seasonal illness. The landscape of vaccination has evolved significantly, with modern ...

Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...

The COVID-19 pandemic demonstrated the promise and power of vaccination to protect society against infectious diseases. However, factors such as shortage of healthcare workers, ineffective supply ...

Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...

Scientists at The Pirbright Institute have taken a major step forward in tackling one of the world's most dangerous viruses, the Nipah virus, by evaluating vaccine candidates for pigs. The Nipah virus ...